Description

Description

Lina-Met XR (2.5mg/850mg) is an extended-release combination tablet for type 2 diabetes, bringing together Linagliptin and Metformin in a formulation designed to release its active ingredients gradually over time. Each pack contains 14 tablets, offering patients a once-daily treatment option that provides steady blood sugar support throughout the day while helping to reduce the frequency of dosing compared to immediate-release combinations. The extended-release design allows for a more gradual absorption of Metformin in particular, which can help minimize the digestive side effects often associated with standard-release Metformin tablets. By combining Linagliptin’s incretin-based mechanism with Metformin’s well-established glucose-lowering action in a slow-release format, Lina-Met XR offers a convenient, steady approach to managing type 2 diabetes as part of a broader treatment plan involving diet and exercise.

Ingredients

Each Lina-Met XR 2.5mg/850mg tablet contains Linagliptin at a 2.5mg strength, combined with Metformin Hydrochloride in its extended-release form at an 850mg strength. Linagliptin belongs to the DPP-4 inhibitor class of medications, working by increasing levels of incretin hormones in the body, which support insulin release after meals while also helping to reduce excess glucose production by the liver. Metformin, from the biguanide class, works differently, primarily lowering the amount of glucose the liver releases into the bloodstream while also decreasing glucose absorption in the intestines and improving the body’s response to its own insulin. The extended-release formulation of Metformin allows this ingredient to be released more gradually, supporting more consistent blood sugar control over a longer period.

Dosage Form

Lina-Met XR 2.5mg/850mg is supplied as an oral extended-release tablet, packaged in a strip format containing 14 tablets, designed to release its active ingredients gradually for sustained blood sugar management.

Uses

Lina-Met XR 2.5mg/850mg is used, alongside a proper diet and exercise routine, to improve blood sugar control in adults with type 2 diabetes mellitus, particularly when treatment with diet, exercise, and standard medications hasn’t achieved adequate glycemic control on its own. It is not intended for the treatment of type 1 diabetes. This combination is often chosen for patients who benefit from the steadier, more gradual glucose control that an extended-release formulation provides, offering a convenient alternative to taking multiple immediate-release doses throughout the day. By supporting healthier insulin activity while reducing the liver’s glucose output, this medication helps patients achieve more consistent, long-term blood sugar management.

How to Use

Lina-Met XR 2.5mg/850mg should be taken once daily with a meal, as directed by your doctor, since taking it with food can help support steady absorption and reduce the likelihood of stomach discomfort. The tablet must be swallowed whole and should never be crushed, split, or chewed, as doing so would interfere with its extended-release mechanism and could result in too much of the medication being released at once. Your doctor will determine the appropriate starting dose based on whether you’re new to these medications or transitioning from another diabetes treatment, and the dosage may be adjusted over time based on your blood sugar response, without exceeding the maximum recommended daily amounts of each active ingredient. If a dose is missed, take it as soon as possible unless it’s nearly time for your next scheduled dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Lina-Met XR can cause side effects similar to those seen with other Linagliptin and Metformin combinations, including nausea, diarrhea, stomach discomfort, and altered taste, particularly during the initial adjustment period. The extended-release formulation is often associated with a somewhat reduced likelihood of digestive side effects compared to immediate-release versions, though individual experiences can vary. As with other Metformin-containing medications, there is a rare but serious risk of lactic acidosis, particularly in patients with kidney or liver impairment, dehydration, heart failure, or heavy alcohol use. Symptoms of lactic acidosis include unusual tiredness, dizziness, muscle pain, difficulty breathing, an irregular heartbeat, or stomach pain with nausea or vomiting, and require immediate medical attention. Hypoglycemia is also possible, especially when this medication is combined with other diabetes treatments, so patients should remain alert to symptoms like sweating, shakiness, or confusion.

Pregnancy & Breastfeeding

The safety of Lina-Met XR during pregnancy has not been well established, so it’s important to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, so an appropriate treatment plan can be discussed. Diabetes management during pregnancy often calls for a different approach, and your doctor will help guide you toward the most suitable option for your specific circumstances. Because components of this medication may pass into breast milk, breastfeeding mothers should consult their doctor before starting or continuing this treatment.

Storage Instructions

Store Lina-Met XR 2.5mg/850mg tablets in a cool, dry place, away from direct sunlight and excess moisture. Keep the tablets in their original packaging until ready for use to help preserve their effectiveness. Store this medication safely out of reach of children and pets, and dispose of any unused or expired tablets responsibly rather than through household waste.

FAQs

Why is this called an “XR” formulation?
XR stands for extended-release, meaning the tablet is designed to release its active ingredients gradually over time, supporting steadier blood sugar control with once-daily dosing.

Can I split or crush the tablet if I have trouble swallowing it?
No, this tablet must be swallowed whole, as crushing or splitting it would interfere with its extended-release mechanism and how the medication is absorbed.

Does the extended-release form reduce stomach side effects?
Many patients experience fewer digestive side effects with extended-release Metformin compared to immediate-release versions, though this can vary from person to person.

How is the dosage determined if I’m switching from another diabetes medication?
Your doctor will base your starting dose on your current treatment and blood sugar levels, adjusting gradually to find the most effective and well-tolerated dose for you.

Is this medication suitable for type 1 diabetes?
No, Lina-Met XR is intended specifically for type 2 diabetes and is not appropriate for type 1 diabetes or diabetic ketoacidosis.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.